Cytochrome P450 CYP 2C19*2 Associated with Adverse 1-Year Cardiovascular Events in Patients with Acute Coronary Syndrome

Open Access

Peer-reviewed

Research Article

You-quan Wei ,

Contributed equally to this work with: You-quan Wei, Dian-gang Wang

Affiliation Department of Cardiology, The First Affiliated Hospital of Wannan Medical College, Wuhu, China
⨯
Dian-gang Wang ,

Contributed equally to this work with: You-quan Wei, Dian-gang Wang

Affiliation Department of Cardiology, The Second People's Hospital of Huangchuan County, Xinyang, China
⨯
Hao Yang,

Affiliation Department of Cardiology, The First Affiliated Hospital of Wannan Medical College, Wuhu, China
⨯
Heng Cao

* E-mail: ablationer@aliyun.com

Affiliation Department of Cardiology, The First Affiliated Hospital of Wannan Medical College, Wuhu, China
⨯

Reader Comments (0)

Antiplatelet therapy
Is the Subject Area "Antiplatelet therapy" applicable to this article?

Thanks for your feedback.
Angina
Is the Subject Area "Angina" applicable to this article?

Thanks for your feedback.
Myocardial infarction
Is the Subject Area "Myocardial infarction" applicable to this article?

Thanks for your feedback.
Thrombosis
Is the Subject Area "Thrombosis" applicable to this article?

Thanks for your feedback.
Cardiovascular disease risk
Is the Subject Area "Cardiovascular disease risk" applicable to this article?

Thanks for your feedback.
Cardiovascular therapy
Is the Subject Area "Cardiovascular therapy" applicable to this article?

Thanks for your feedback.
Platelet aggregation
Is the Subject Area "Platelet aggregation" applicable to this article?

Thanks for your feedback.
Platelets
Is the Subject Area "Platelets" applicable to this article?

Thanks for your feedback.